A Phase I Study of ZD1839 (Iressa) and Palliative Thoracic Radiotherapy in Patients With Non-small Cell Lung Cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2011
At a glance
- Drugs Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 26 Nov 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 20 Nov 2006 Status change
- 29 Dec 2005 New trial record.